Primary information |
---|
CancerPDF_ID | CancerPDF_ID3402 |
PMID | 24565027 |
Peptide Sequence | QTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLIGLLHSSVK |
Peptide Sequence in Publication | QTPKHISESLGAEVDPDMSWSSSLATPPTLSSTVLI(G)LLHSSVK |
Protein Name | Breast cancer type 2 susceptibility protein |
UniprotKB Entry Name | BRCA2_HUMAN |
Biofluid | Plasma |
M/Z | NA |
Charge | NA |
Mass/H+ | NA |
Mass (in Daltons) | NA |
Profiling Technique | Linear ion-trap mass spectrometer (LTQ) coupled with a Surveyor HPLC-MS |
Peptide Identification Technique | MS/MS |
Quantification Technique | NA |
Labeling | Label Free |
FDR | 0.05 |
p-Value | less than 0.05 |
Software | SEQUEST and OMSSA |
Length of Peptide | 44 |
Cancer Type | Breast cancer |
Database for Peptide search | SASD (Synthetic Alternative Splicing Database) |
Modification | NA |
Number of Patients | 40 cancer patients for each training and testing set; 40 normal individuals for each training and testing set |
Regulation/Differential Expression | Differentially expressed between normal and patients |
Validation | Independent validation |
Sensitivity | NA |
Specificity | NA |
Accuracy | NA |
Secondary information |
---|
Peptide Atlas | NA |
IEDB | |